Hrvoje Budincevic

Osijek, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study.

Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: June 19, 2026

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: June 19, 2026

Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study.

Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study.

Journal: Journal of neurology

Published: May 20, 2026

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

Journal: JAMA network open

Published: April 28, 2026

Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation.

Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation.

Journal: Neurology

Published: April 13, 2026

Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability-weighted analysis.

Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability-weighted analysis.

Journal: Journal of the neurological sciences

Published: April 01, 2026

Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis.

Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA-R Inverse Probability Weighted Analysis.

Journal: Journal of the American Heart Association

Published: March 31, 2026

Accessibility and use of organised stroke care and reperfusion therapies in Europe: results from the SAP-E Stroke Service Tracker 2023.

Accessibility and use of organised stroke care and reperfusion therapies in Europe: results from the SAP-E Stroke Service Tracker 2023.

Journal: European stroke journal

Published: March 21, 2026

Cilostazol/Extract of Ginkgo biloba or Aspirin, What Is the Treatment in Atherosclerosis Prevention? (Diabetes Metab J 2026;50:357-67).

Cilostazol/Extract of Ginkgo biloba or Aspirin, What Is the Treatment in Atherosclerosis Prevention? (Diabetes Metab J 2026;50:357-67).

Journal: Diabetes & metabolism journal

Published: December 16, 2025

Status on stroke and stroke care in Europe 2023: Stroke Service Tracker 2023 data based on 1,460,360 strokes in 47 European nations.

Status on stroke and stroke care in Europe 2023: Stroke Service Tracker 2023 data based on 1,460,360 strokes in 47 European nations.

Journal: European stroke journal

Published: December 06, 2025

Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.

Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.

Journal: European stroke journal

Published: November 20, 2025

COVID-19 and Atherosclerosis: Is There an Association? Comment on Bielecka et al. From Systemic Inflammation to Vascular Remodeling: Investigating Carotid IMT in COVID-19 Survivors. Viruses 2025, 17, 1196.

COVID-19 and Atherosclerosis: Is There an Association? Comment on Bielecka et al. From Systemic Inflammation to Vascular Remodeling: Investigating Carotid IMT in COVID-19 Survivors. Viruses 2025, 17, 1196.

Journal: Viruses

Published: November 19, 2025

Showing 1-12 of 61

Last Updated: 09/26/2026